Kala Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.10-$20.60 |
Market Cap | $133.7M |
Shares Short | 650,969 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $1.3M |
Diluted EPS | -$5.30 |
News
See moreYahoo Finance • 2 months ago
KALA BIO Non-GAAP EPS of -$1.71
Yahoo Finance • 2 months ago
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 2 months ago
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
Yahoo Finance • 3 months ago
Kala Bio completes enrollment in Phase 2b trial for KPI-012 in eye disorder
About
CEO | Mr. Todd Bazemore |
Address | 1167 Massachusetts Avenue, Arlington, MA, United States, 02476 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 38 |
